1. Home
  2. BHVN vs NWN Comparison

BHVN vs NWN Comparison

Compare BHVN & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • NWN
  • Stock Information
  • Founded
  • BHVN 2013
  • NWN 1859
  • Country
  • BHVN United States
  • NWN United States
  • Employees
  • BHVN N/A
  • NWN N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • NWN Oil/Gas Transmission
  • Sector
  • BHVN Health Care
  • NWN Utilities
  • Exchange
  • BHVN Nasdaq
  • NWN Nasdaq
  • Market Cap
  • BHVN 1.9B
  • NWN 1.7B
  • IPO Year
  • BHVN 2017
  • NWN N/A
  • Fundamental
  • Price
  • BHVN $16.52
  • NWN $47.70
  • Analyst Decision
  • BHVN Strong Buy
  • NWN Buy
  • Analyst Count
  • BHVN 14
  • NWN 2
  • Target Price
  • BHVN $49.23
  • NWN $48.00
  • AVG Volume (30 Days)
  • BHVN 2.1M
  • NWN 222.8K
  • Earning Date
  • BHVN 11-11-2025
  • NWN 11-05-2025
  • Dividend Yield
  • BHVN N/A
  • NWN 4.10%
  • EPS Growth
  • BHVN N/A
  • NWN 17.48
  • EPS
  • BHVN N/A
  • NWN 2.58
  • Revenue
  • BHVN N/A
  • NWN $1,238,288,000.00
  • Revenue This Year
  • BHVN N/A
  • NWN $17.95
  • Revenue Next Year
  • BHVN $2,079.03
  • NWN $5.66
  • P/E Ratio
  • BHVN N/A
  • NWN $18.52
  • Revenue Growth
  • BHVN N/A
  • NWN 8.40
  • 52 Week Low
  • BHVN $12.79
  • NWN $38.03
  • 52 Week High
  • BHVN $54.98
  • NWN $47.79
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 54.24
  • NWN 77.69
  • Support Level
  • BHVN $16.30
  • NWN $46.76
  • Resistance Level
  • BHVN $18.18
  • NWN $47.73
  • Average True Range (ATR)
  • BHVN 1.26
  • NWN 0.74
  • MACD
  • BHVN 0.02
  • NWN 0.23
  • Stochastic Oscillator
  • BHVN 55.52
  • NWN 99.51

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: